ZD-2767-P ADEPT therapeutic (Cancer Research)

N/A

Report date: 2023/11/30 17:37:31

Base Information

Drug NameZD-2767-P ADEPT therapeutic (Cancer Research)
Drug Alias NameMFE-23:CPG2 targeted ZD-2767-P ADEPT (cancer)MFECP1MFE-23:CPG2
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCarcinoembryonic antigen modulators
TargetsCarcinoembryonic antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research UK
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A